Terrific Molecular Therapeutics division retreat! What an amazing day of science and community. And an inspiring keynote lecture from Neil Bence Bristol Myers Squibb!! 👏 🤩

Thank you to everyone for making the 3rd MTx retreat UC Berkeley MCB Molecular Therapeutics Initiative such an exciting day of brilliant science and community! Amazing work at the interface of basic biology, drug discovery, and drug delivery presented by students and postdocs of MTx. #inspired

Please RT and help us get the word out. Scott Dixon @sjd956 and I are co-organizing the first FASEB #Ferroptosis conference this summer! Awesome line up of speakers and room for additional short talks! Save the date & come join us July 27 - 31, 2025! 🤩events.faseb.org/event/11797f9e…

I’m happy to share this good news from ⁦⁦USP - Universidade de São Paulo⁩ ! 🥳 A huge thank you to all the professors, lab colleagues, and friends who played an essential role in the development of my thesis and the resulting articles!! ⁦⁦Miyamoto Lab⁩ redoxoma.iq.usp.br/news.php/alex-…

Our Molecular Therapeutics department UC Berkeley is looking for a Metabolomics Specialist! If you're skilled in untargeted and targeted metabolomics applications and want to contribute to the discovery of novel biology and drugs then this is for you! aprecruit.berkeley.edu/JPF04656

Online Now: PRDX6 contributes to selenocysteine metabolism and ferroptosis resistance dlvr.it/TGB651

Grateful to UC Berkeley MCB for highlighting our lab and our recent discoveries! It was fun to discuss some of the surprises during our research on lipid homeostasis, lipid droplets, & ferroptosis—driven by exceptional UC Berkeley students & postdocs. mcb.berkeley.edu/news-and-event…

Immunologist Dr. Gabriel D. Victora shares how he changed career paths from classical pianist to immunologist and discusses the importance of not letting technological limitations get in the way. #50ScientistsThatInspire #CP50 Read the full interview: cell.com/news-do/50-ins…

New paper is out!🎄🥳 Identification of Novel Human 15-Lipoxygenase-2 (h15-LOX-2) Inhibitors Using a Virtual Screening Approach. Congratulations to all authors! Lucas Viviani, Thais Iijima, Erika Piccirllo, Leandro Rezende, Thiago Alegria, Luis Neto + pubs.acs.org/doi/10.1021/ac…

Excited to share our new preprint! Exceptional work by postdoc @MikeLange identifies the first #LipidDroplet lipid quality control pathway! Droplet-localized FSP1 safeguards stored neutral lipids, blocking their peroxidation & #ferroptosis induction.🤩biorxiv.org/content/10.110…

Reminder: The 1st FASEB #Ferroptosis Meeting is this summer! Spectacular speaker lineup + short talks selected from submitted abstracts. It is going to be awesome! Trainees, newcomers & all interested are welcome! 📅 Abstract deadline: June 1, 2025. shorturl.at/QA6T1

Exciting new work from Logan Leak & Scott Dixon in Nature Chemical Biology! Tegavivint, a clinical-stage drug, triggers a novel lipid-dependent nonapoptotic cell death via TECR and palmitate synthesis. Very cool! 🤩 nature.com/articles/s4158…

My lab's first paper is out in nature. We show that lipoprotein uptake protects tumors from ferroptosis by delivering the lipid antioxidant α-tocopherol. Surprisingly, tumors use sulfated glycosaminoglycans—not canonical receptors—to capture lipoproteins. nature.com/articles/s4158…

🎉Congrats to our 2025 biomedical scholars and fellows! These 37 early-career scientists are embarking on innovative research projects in neuroscience, microbiology, cancer research, and more. pewtrsts.org/4mg4l01

Congratulations to UC Berkeley Metabolic Biology professor Ana Paula Arruda and postdoc Alex Inague, who each received multiyear grants from The Pew Trusts to support their research and professional growth. Read more: linkedin.com/pulse/two-nst-…

Happy to have contributed in a small way to this exciting story from Fangzhu Zhao and Jim Wells now out in J. Am. Chem. Soc.. "Hijacking Extracellular Targeted Protein Degrader–Drug Conjugates for Enhanced Drug Delivery" pubs.acs.org/doi/10.1021/ja…

An absolute privilege and joy to work with this exceptional group of scientists at UC Berkeley. ☺️#NewLabPhoto

Excited to share our new study out in Nature Cell Biology! Led by postdoc MikeLange, we identify the first #LipidDroplet lipid quality control pathway: LD-localized FSP1 protects stored lipids from oxidative damage and prevents LD-initiated #ferroptosis. nature.com/articles/s4155…

Proud for being launching our Center of Metabolism at USP!!! Together with my colleagues Alicia Kowaltowski Sayuri Miyamoto e Marilia Seelander we are creating CoMeta. Take a look below to know more about this: jornal.usp.br/uspnews/new-us…

Vitória brasileira: Fruto do esforço científico nacional, a Butantan-DV começou a ser desenvolvida em 2009, quando o Brasil enfrentava recordes de dengue. Foram 270 experimentos e 50 tentativas de formulação até chegar ao produto final. Saiba mais: tinyurl.com/mrx8ah2k